Scientific Prompting: The Missing Intelligence Layer in AI-Driven Drug Discovery

access_time 2026-01-16T05:11:33.696Z face Shruti Joshi
Scientific Prompting: The Missing Intelligence Layer in AI-Driven Drug Discovery MolecuNex AI 16.1.26 Artificial intelligence is now deeply embedded across drug discovery virtual screening, target identification, pathway analysis, predictive toxicology, and clinical translation. Yet despite the grow...

Evidence-Backed Branding: How Predictive & Clinical Studios Support Honest Product Claims

access_time 2026-01-16T05:09:51.142Z face Shruti Joshi
Evidence-Backed Branding: How Predictive & Clinical Studios Support Honest Product Claims SwaLife Consultancy 16.01.26 In health, wellness, and life-science markets, branding is no longer driven by storytelling alone. Regulators, partners, and increasingly well-informed consumers now expect claims t...

From Traditional Knowledge to Modern Science: The SwaLife Studio Approach

access_time 2026-01-13T05:39:11.022Z face Shruti Joshi
From Traditional Knowledge to Modern Science: The SwaLife Studio Approach SwaLife Consultancy 13.01.26 Across cultures, traditional herbal knowledge has supported health and wellness for generations. Today, companies working with herbal products face a different reality proof, precision, and process...

RNA-seq-Driven Evaluation of Herbal Formulations in Experimental Cancer Prevention

access_time 2026-01-13T05:34:17.026Z face Shruti Joshi
RNA-seq-Driven Evaluation of Herbal Formulations in Experimental Cancer Prevention SwaLife Biotech 13.01.26 The role of herbal formulations in cancer prevention is gaining renewed scientific attention but with a critical shift. Traditional efficacy claims are no longer sufficient. Today, mechanistic...

Identifying Endpoints for Safety, Efficacy, and Quality of Life in Real-World Trials

access_time 2026-01-13T05:32:24.881Z face Shruti Joshi
Identifying Endpoints for Safety, Efficacy, and Quality of Life in Real-World Trials SSTSI 13.01.26 Clinical research is undergoing a quiet but powerful shift. While randomized controlled trials (RCTs) remain the gold standard for regulatory approval, real-world trials are increasingly shaping how t...